| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |